1218-P: All-Cause Mortality in Individuals Aged 65+ Years with Type 2 Diabetes With and Without Frailty—Clinical Utility of Electronic Frailty Index to Individualise HbA1c Targets... von CRABTREE, THOMAS S.J., VINOGRADOVA, YANA, ALDAFAS, RAMI, GORDON, JASON, IDRIS, ISKANDAR R.

Volltext

Patient-reported outcomes in studies of diabetes technology: What matters von Liarakos, Alexandros L, Crabtree, Thomas S J, Wilmot, Emma G

Volltext

Health-care professional opinions of DIY artificial pancreas systems in the UK von Crabtree, Thomas S J, Choudhary, Pratik, Hammond, Peter, Lumb, Alistair, McLay, Alasdair, Wilmot, Emma G

Volltext

DIY artificial pancreas systems: here to stay? von Crabtree, Thomas SJ, McLay, Alasdair, Wilmot, Emma G

Volltext

787-P: Glucose and Weight Outcomes Associated with Oral Semaglutide in the Real-World—Initial Results from the Association of British Clinical Diabetologists’ (ABCD) Audit von CRABTREE, THOMAS S.J., ADAMSON, KAREN, KRISHNASAMY, SENTHILKUMAR, THIN KHINE, MAY, DE, PARIJAT, PETER, RAJESH, RYDER, ROBERT E.

Volltext

907-P: Glycaemic Outcomes Associated with Omnipod DASH Use in the Real World—Results from the Association of British Clinical Diabetologists (ABCD) Omnipod Worldwide Audit von CRABTREE, THOMAS S.J., HAQ, MASUD, HASAN, NEBRAS, WILLIAMS, DAVID M., GATDULA, ERNEDA R., CHINNASAMY, ESWARI, VARGHESE, JEANNY, MODGIL, GITA, RYDER, ROBERT E., WILMOT, EMMA G.

Volltext

858-P: Predictors of HbA1c and Weight Response to Sodium–Glucose Cotransporter 2 Inhibitors (SGLT2i) in the Association of British Clinical Diabetologist (ABCD) UK Nationwide Audit... von CRABTREE, THOMAS S.J., GALLAGHER, ALISON, SIVAPPRIYAN, SIVA, DHATARIYA, KETAN, RAGHAVAN, RAJEEV P., BICKERTON, ALEX, ELLIOTT, JACKIE, CULL, MELISSA L., RAYMAN, GERRY, GALLEN, IAN W., IDRIS, ISKANDAR R., RYDER, ROBERT E.

Volltext

686-P: The Association of British Clinical Diabetologists (ABCD) United Kingdom Nationwide Semaglutide Audit von CRABTREE, THOMAS S.J., BICKERTON, ALEX, SENNIK, DEVESH K., ROHILLA, ANURITA, SIVAPPRIYAN, SIVA, BARNES, DENNIS, CULL, MELISSA L., GALLEN, IAN W., ADAMSON, KAREN, RYDER, ROBERT E.

Volltext

We are not waiting - DIY APS Do-It-Yourself Artificial Pancreas Systems: The story so far von Crabtree, Thomas, Ryder, Bob, Wilmot, Emma

Volltext

Gazing into the future – the next 100 years. Perspectives from diabetologists von Ryder, Robert, Wilmot, Emma, Crabtree, Thomas

Volltext

1105-P: The Effect of Canagliflozin on Alanine Aminotransferase (ALT) Levels: Data from the Association of British Clinical Diabetologists (ABCD) Nationwide Audit Programme von CRABTREE, THOMAS S.J., PHILLIPS, SUZANNE M., EVANS, ALISON, SENNIK, DEVESH K., ROHILLA, ANURITA, BICKERTON, ALEX, DARZY, KEN H., WINOCOUR, PETER, CULL, MELISSA L., STRZELECKA, ANNA, RAGHAVAN, RAJEEV P., GALLEN, IAN W., YADAGIRI, MAHENDER, RYDER, ROBERT E.

Volltext

Imeglimin, a novel, first in-class, blood glucose-lowering agent: a systematic review and meta-analysis of clinical evidence von Crabtree, Thomas SJ, DeFronzo, Ralph A, Ryder, Robert E J, Bailey, Clifford J

Volltext

Freestyle Libre: available on the NHS? von Crabtree, Thomas SJ, Sathyapalan, Thozhukat, Wilmot, Emma

Volltext

Effects of canagliflozin are mostly observed at first follow-up, within 6 months of commencement: results for the ABCD canagliflozin audit von Crabtree, Thomas SJ, Winocour, Peter, Darzy, Ken, Phillips, Suzanne, Evans, Alison, Rohilla, Anurita, Raghavan, Rajeev, Sennik, Devesh, Bickerton, Alex, Idris, Iskandar, Yadagiri, Mahender, Ryder, Robert EJ, Canagliflozin Audit Contributors, ABCD

Volltext

The effect of dapagliflozin on alanine aminotransferase as a marker of liver inflammation: updated results from the ABCD dapagliflozin audit von Crabtree, Thomas SJ, Yadagiri, Mahender, Gallen, Ian, Phillips, Suzanne, Evans, Alison, Rohilla, Anurita, Bickerton, Alex, Rowles, Susannah, Idris, Iskandar, Ryder, Robert E J, Dapagliflozin audit contributors, On behalf of the ABCD

Volltext

Reductions in alanine aminotransferase levels with liraglutide treatment are greatest in those with raised baseline levels and are independent of weight loss: real-world outcome da... von Crabtree, Thomas SJ, Rowles, Susannah, Tarpey, Stephanie, Kennedy, Adele, Chalmers, John, Nayar, Rahul, Lee, Amanda, Darzy, Ken, Winocour, Peter, Lindsay, John, Idris, Iskandar, Thong, Ken Y, Sen Gupta, Piya, Puttanna, Amar, Kumar, Pranav, Ryder, Robert EJ, Nationwide Audit Contributors, On Behalf of ABCD

Volltext

Impact of glycaemic technologies on quality of life and related outcomes in adults with type 1 diabetes: A narrative review von Speight, Jane, Choudhary, Pratik, Wilmot, Emma G., Hendrieckx, Christel, Forde, Hannah, Cheung, Wai Yee, Crabtree, Thomas, Millar, Bekki, Traviss‐Turner, Gemma, Hill, Andrew, Ajjan, Ramzi A.

Volltext

Insulin pumps and diabetes technologies in pregnancy: an overview for the obstetrician von Crabtree, Thomas SJ, Gazis, Anastasios

Volltext

803-P: The Association between Empagliflozin and Changes in Alanine Aminotransferase Levels: Data from the Association of British Clinical Diabetologists (ABCD) Audit Programme von CRABTREE, THOMAS S.J., ELLIOTT, JACKIE, BICKERTON, ALEX, GALLEN, IAN W., DHATARIYA, KETAN, CULL, MELISSA L., EVANS, ALISON, PHILLIPS, SUZANNE M., RYDER, ROBERT E.

Volltext

UK's Association of British Clinical Diabetologist's Diabetes Technology Network (ABCD‐DTN): Best practice guide for hybrid closed‐loop therapy von Griffin, Tomás P., Gallen, Geraldine, Hartnell, Sara, Crabtree, Thomas, Holloway, Melissa, Gibb, Fraser W., Lumb, Alistair, Wilmot, Emma G., Choudhary, Pratik, Hussain, Sufyan

Volltext